When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MGTX - MeiraGTx teams up with Janssen to develop gene therapies for inherited retinal disorders
MeiraGTx Holdings plc
MeiraGTx (NASDAQ:MGTX) inks a collaboration agreement with Johnson & Johnson (NYSE:JNJ) unit Janssen Pharmaceutical to develop and commercialize gene therapies for the treatment of inherited retinal diseases (IRDs), including MGTX's candidates for achromatopsia (partial or total absence of color vision) caused by mutations in genes CNGB3 or CNGA3 and X-linked retinitis pigmentosa (XLRP) (leads to blindness in men).
More news on: MeiraGTx Holdings plc, Johnson & Johnson, Healthcare stocks news, Stocks on the move,